Blog
RSS FeedPosted by Michael Wonder on 23 Apr 2019
Additional embargo period following revised CDEC recommendations
17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...
Posted by Michael Wonder on 17 Apr 2019
Increasing access to new treatments for special patient populations
16 April 2019 - Health Canada is helping Canadians get timely access to new drugs. ...
Posted by Michael Wonder on 15 Apr 2019
Big pharma might cut research, delay new drugs if Pharmacare means more generics
14 April 2019 - Pharmacare is shaping up as a key campaign issue in the October election, particularly for the Liberals. ...
Posted by Michael Wonder on 10 Apr 2019
Canada needs to read the fine print on pharma costs
10 April 2019 - The proposed federal price controls for patented medicines will send the wrong signal to Canadian and global ...
Posted by Michael Wonder on 04 Apr 2019
Ontario woman with rare disease forced to pay hundreds of thousands to cover ‘miracle drug’
3 April 2019 - For 21 years, a Whitby woman and her family have been in and out of hospitals, ...
Posted by Michael Wonder on 29 Mar 2019
Canada’s amendment to patented drug price regulation: a prescription for global drug cost control?
29 March 2019 - The cost of drugs in the United States has emerged as a focal point for reducing overall ...
Posted by Michael Wonder on 28 Mar 2019
National pharmacare to make prescription drugs more accessible and affordable
28 March 2019 - Canadians pay too much for prescription drugs – and that means far too many go without ...
Posted by Michael Wonder on 25 Mar 2019
Canadian public places high priority on drugs’ safety, effectiveness, and certainty of evidence
25 March 2019 - Survey reveals top values for drug coverage decision making. ...
Posted by Michael Wonder on 25 Mar 2019
One Canadian payer's experience with biosimilars
25 March 2019 - Much of the discussion about biosimilar uptake revolves around challenges in the United States, but other ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...
Posted by Michael Wonder on 20 Mar 2019
Where is the champion for Pharmacare?
20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...
Posted by Michael Wonder on 20 Mar 2019
National drug agency touted as building block of Pharmacare plan
19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...
Posted by Michael Wonder on 20 Mar 2019
Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS
19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...
Posted by Michael Wonder on 20 Mar 2019
Canada to create national drug agency to help cut cost of medicines
20 March 2019 - Canada will create a national drug agency to help cut the cost of prescription medications as part ...